Icotrokinra

伊可白滞素

Report date: 2026/03/26 20:00:17
NME

Base Information

Drug NameIcotrokinra
Drug Alias Name盐酸伊可白滞素ICOTYDEJNJ-77242113PN-235JNJ-2113 +[7] 
ClassificationSmall molecules > Synthetic peptide
Mechanisms of ActionInterleukin 23 Receptor antagonists
TargetsInterleukin 23 Receptor
Therapy Area/IndicationsPlaque psoriasisGeneralised pustular psoriasisErythrodermic psoriasis +[7] 
Global Approved IndicationsPlaque psoriasis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date2026/03/17
Country/TerritoryCzechiaBelgiumBulgaria +[40] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaNDA/BLA
Originator CompaniesProtagonist Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesJohnson & Johnson (China) Investment LtdJanssen-Cilag International NvJanssen Pharmaceutica NV +[8] 
Inactive CompaniesN/A
Active IndicationsPlaque psoriasisGeneralised pustular psoriasisErythrodermic psoriasis +[7] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksKEGG